SCHEMBL6022348

SCHEMBL6022348

Cn1c(=O)cc(C(F)(F)F)c2cc(S(=O)(=O)N(CCO)Cc3ccccc3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.53
HPGD P15428 4/20 0.44
HTT P42858 2/20 0.44
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 2/20 0.43
PKM P14618 1/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NR1H4 Q96RI1 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
PTPN1 P18031 1/20 0.40
CNR2 P34972 1/20 0.40
BACE1 P56817 1/20 0.40
GAA P10253 1/20 0.39
POLB P06746 2/20 0.39
TP53 P04637 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022248 0.92 RXFP1 (0.51) RXFP1MAPK1KDM4EPKMSMN1; SMN2
SCHEMBL6022153 0.89 RXFP1 (0.51) RXFP1HPGDMAPK1KDM4EPKM
SCHEMBL6022647 0.85 KDM4E (0.51) RXFP1HPGDKDM4ELMNASMN1; SMN2
SCHEMBL6022256 0.81 MAPK1 (0.48) RXFP1MAPK1KDM4EPKMSMN1; SMN2
SCHEMBL6023232 0.79 AR (0.55) RXFP1ALDH1A1KMT2AMEN1MAPT
SCHEMBL6023077 0.79 KDM4E (0.61) RXFP1HPGDKDM4EPKMLMNA
SCHEMBL6022392 0.78 POLB (0.49) MAPK1KDM4EPKMPOLBHTR2C
SCHEMBL6022142 0.77 NR3C1 (0.55) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL6022484 0.73 ALDH1A1 (0.62) MAPK1KDM4EPKMLMNAALDH1A1
SCHEMBL6022453 0.73 AR (0.48) HPGDALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7009052-B2 Sulfonamide derivatives WARNER LAMBERT COMPANY LLC (US) 2006-03-07 US claimed
US-20050004367-A1 Sulfonamide derivatives DU DANIEL Y (US) 2005-01-06 US claimed
US-7009052-B2 Sulfonamide derivatives WARNER LAMBERT COMPANY LLC (US) 2006-03-07 US disclosed
US-20050004367-A1 Sulfonamide derivatives DU DANIEL Y (US) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004367-A1 Sulfonamide derivatives AR, SULT2A1, SHBG RXFP1 1706/4885HPGD 1572/4885HTT 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.